ЮРАК ИШЕМИК КАСАЛЛИГИ БЎЛГАН БЕМОРЛАРДА КОРОНАР СТЕНТЛАШ АМАЛИЁТИДАН СЎНГ ОЛИБ БОРИЛГАН АНТИТРОМБОТИК ТЕРАПИЯ САМАРАДОРЛИГИНИ БАҲОЛАШ.
Аннотация
Юрак ишемик касалликлари дунё бўйича ўлимнинг асосий сабабларидан бири бўлиб, ҳар йили 17 миллиондан ортиқ инсон ҳаётига зомин бўлади [1,2]. Перкутан коронар интервенция (ПКИ) ва стентлаш усулларининг жорий қилиниши орқали беморларнинг прогнозини яхшилаш мумкин бўлди, аммо рестеноз ва тромбоз хавфи сақланиб қолмоқда [3,4]. Шу сабабли ПКИдан кейин самарали антиромботик терапияни танлаш жуда муҳим ҳисобланади.
Библиографические ссылки
A.T. Akhmedov (2024). Impact of cytokines on the onset and progression of arterial hypertension. Eurasian Journal of Medical and Natural Sciences, 4 (6), 116-123. doi: 10.5281/zenodo.12154505.
Akhmedov, A. T., & Sharipov, Z. R. (2023). The role of cytokines in the development of arterial hypertension. Int J Med Sci Clin Res, 3(03), 59-67.
Neumann, F. J., Sousa-Uva, M., Ahlsson, A., et al. (2019). 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, 40(2), 87–165. https://doi.org/10.1093/eurheartj/ehy394
Ridker, P. M., Everett, B. M., Thuren, T., et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377(12), 1119–1131. https://doi.org/10.1056/NEJMoa1707914
Roth, G. A., Mensah, G. A., Johnson, C. O., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Sambu, N., & Curzen, N. (2012). Monitoring the effectiveness of antiplatelet therapy: Opportunities and limitations. British Journal of Clinical Pharmacology, 74(4), 642–653. https://doi.org/10.1111/j.1365-2125.2012.04204.x
Stone, G. W., Rizvi, A., Newman, W., et al. (2019). Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. New England Journal of Medicine, 362(18), 1663–1674. https://doi.org/10.1056/NEJMoa1000480
Valgimigli, M., Bueno, H., Byrne, R. A., et al. (2018). 2017 ESC Focused Update on dual antiplatelet therapy in coronary artery disease. European Heart Journal, 39(3), 213–260. https://doi.org/10.1093/eurheartj/ehx419
Wiviott, S. D., Braunwald, E., McCabe, C. H., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 357(20), 2001–2015. https://doi.org/10.1056/NEJMoa0706482
World Health Organization. (2023). Cardiovascular diseases (CVDs). WHO.
